Azelon Pharmaceuticals (West Conshohocken, PA) a preclinical-stage pharmaceutical company focused on osteoporosis, closed a $4.5M Series A financing. Participants include Prospect Venture Partners, Lighthouse Capital Partners and Covington Venture Fund.